February 2, 2021 Experience Ocumension Therapeutics HK$793.8 million top-up placement of shares We advised the placing agent in connection with the equity offering
February 2, 2021 Experience Ronshine China Holdings $200 million high-yield notes offering We advised the initial purchasers on the Regulation S offering
February 2, 2021 Experience Venus Medtech HK$1.4 billion placing of new H shares We advised Venus Medtech (Hangzhou) on its placement of new shares
January 26, 2021 Experience Guorui Properties exchange offer and consent solicitation We advised the dealer manager on the transaction
January 26, 2021 Experience Primavera Capital Acquisition $414 million IPO We advised Primavera, a SPAC, on its IPO and NYSE listing
January 25, 2021 Experience Innovent Biologics HK$4.73 billion placement of shares We advised the joint placing agents in connection with the equity offering
January 25, 2021 Experience Ronshine China Holdings $300 million high-yield notes offering We advised the initial purchaser on the Regulation S offering
January 21, 2021 Experience Nippon Life Insurance $1.6 billion subordinated notes offering We advised Nippon Life Insurance on its Rule 144A / Regulation S offering
January 20, 2021 Experience RiseSun Real Estate Development $300 million high-yield notes offering We advised the initial purchasers on the Regulation S offering
January 14, 2021 Experience Hopson Development $400 million high-yield notes offering We advised the initial purchasers on the Regulation S offering